Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. (301096) — Tangible Net Worth Ratio
Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. (301096) has a Tangible Net Worth Ratio of 96.4% as of March 2026. This metric is calculated by deducting intangible assets (CN¥89.13 Million) from net assets (CN¥2.50 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore net asset growth rate of Hangzhou Bio-Sincerity Pharma-Tech Co.Lt to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. Tangible Net Worth Ratio (2019–2025)
This chart shows how Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd.'s Tangible Net Worth Ratio has changed across 7 annual periods from 2019 to 2025. As of March 2026, the ratio stands at 96.4%, reflecting net assets of CN¥2.50 Billion with intangible assets of CN¥89.13 Million CNY. For live market cap and overall valuation, see 301096 market cap.
Annual Tangible Net Worth Ratio for Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. (2019–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. from 2019 to 2025, covering 7 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. Explore Hangzhou Bio-Sincerity Pharma-Tech Co.Lt capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 96.4% | CN¥2.49 Billion | CN¥89.80 Million | CN¥3.69 Billion | ▲ +0.0 pp |
| 2024 | 96.4% | CN¥2.58 Billion | CN¥93.43 Million | CN¥3.72 Billion | ▼ -0.2 pp |
| 2023 | 96.6% | CN¥2.68 Billion | CN¥92.07 Million | CN¥3.67 Billion | ▼ -0.1 pp |
| 2022 | 96.7% | CN¥2.48 Billion | CN¥82.37 Million | CN¥2.93 Billion | ▼ -0.7 pp |
| 2021 | 97.4% | CN¥2.32 Billion | CN¥60.79 Million | CN¥2.92 Billion | ▲ +15.6 pp |
| 2020 | 81.7% | CN¥339.54 Million | CN¥62.03 Million | CN¥658.75 Million | ▲ +2.2 pp |
| 2019 | 79.6% | CN¥278.74 Million | CN¥57.00 Million | CN¥378.63 Million | — |